6° Simposio medico annuale ECD Orlando, FL

Julio Hahdenberg, MD
Orlando Health & University of Florida Health Cancer Center
Orlando, FL
1º aprile 2018

Foto di gruppo del Simposio Medico di Orlando 2018

Sintesi del simposio

Circa 44 professionisti medici provenienti da sei paesi hanno partecipato al Simposio Medico Annuale ECD nel 2018. Sono stati presentati dieci abstract orali, insieme a sei presentazioni poster aggiuntive. Come relatore invitato, Matthew Collin ha tenuto un intervento intitolato “Erdheim-Chester Disease: Cancer, but not as we know it”. Un ricevimento serale ha offerto tempo per discussioni a sostegno delle collaborazioni attuali e future tra questo gruppo altamente qualificato di medici e scienziati, tutti interessati ad approfondire la conoscenza della malattia di Erdheim-Chester.

Esperienze dei partecipanti

“[[La ECD Global Alliance] ha aiutato me e i miei pazienti] riunendo gli esperti per compiere progressi collaborativi.”

– Ronald S. Go, MD, Partecipante 2018

Programmi con l’agenda del simposio

Presentazioni

PresenterPresentation SlidesEnglish Video
Julio Hajdenberg, MDWelcome AddressNot Available
Matthew Collin, MD, PhDErdheim Chester Disease: Cancer, but not as we know it.Not Available
Eli L. Diamond, MDPatient-reported outcomes in adults with Erdheim-Chester Disease: Early findings from the ECD RegistryNot Available
Benjamin Durham, MDNovel Activating Mutations in CSF1R and Additional Receptor Tyrosine Kinases in Histiocytic NeoplasmsNot Available
Ran Weissman, M.ScThe role of microRNAs in the Pathogenesis of Erdheim-Chester Disease and their Potential Use as Biomarkers for Diagnosis and Prognosis of the DiseaseNot Available
Julien Haroche, MD, PhDSlide deck not availableImaging aspect of cardiac involvement in Erdheim-Chester disease: cardiac CT and MRI of 188 patients
Gaurav Goyal, MDTumor mutational burden and other immunotherapy markers in Erdheim-Chester disease and other histiocytic neoplasmsTumor mutational burden and other immunotherapy markers in Erdheim-Chester disease and other histiocytic neoplasms
Anaïs Roeser, MDAuto-immunity in L-group histiocytosesAuto-immunity in L-group histiocytoses
Roei Mazor, MDEfficacy of Dual BRAF/MAP2K1 Blockade in BRAF mutant Erdheim Chester Disease PatientsNo Videos available
Skand Shekhar, MDHypothyroidism in Erdheim-Chester Disease: Experience from the National Institutes of HealthNo Videos available
Gordon Ruan, MDAcute Pancreatitis from treatment with BRAF-inhibitors in patients with Erdheim-Chester DiseaseAcute Pancreatitis from treatment with BRAF-inhibitors in patients with Erdheim-Chester Disease
Eli L. Diamond, MDPanel Discussion: TOXICITY OF ECD THERAPIESNo Videos available
Julio Hajdenberg, MDPanel Discussion: COMPLEX CASE STUDIESNo Videos available
Kathleen BrewerECDGA AnnouncementsNo Videos available

Fotografie

Simposio medico

Incontro medico